| Independent Reports (Showing 1 to 10 of 25) |
Release Date ![[down]](http://us.i1.yimg.com/us.yimg.com/i/fi/down.gif) |
Contributor |
Author |
Title |
Pages |
Price |
More Info |
| 9-Feb-10 | New Constructs, LLC | N/A | SYK: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings | 19 | $10 | View Abstract |
| 9-Feb-10 | Pechala's Reports | Lubomir Pechala | STRYKER CORPORATION (SYK=US) - REPORT FOR ACTIVE TRADERS | 4 | $25 | View Abstract |
| 9-Feb-10 | Stock Traders Daily | Thomas H. Kee Jr. | Trading Report for (SYK). A detailed Technical Analysis + Trading Plans for Day Trading, Swing Trading, and Long Term proactive investments in (SYK). | 5 | $18 | View Abstract |
| 8-Feb-10 | ValuEngine, Inc. | N/A | ValuEngine Detailed Valuation Report for SYK | 13 | $25 | View Abstract |
| 8-Feb-10 | Market Edge | N/A | Market Edge Equity Research Report | 4 | $10 | View Abstract |
| 8-Feb-10 | PriceTarget Research, Inc. | N/A | Stryker Corporation has a current Overall Rating of B (Positive). | 7 | $25 | View Abstract |
| 7-Feb-10 | Wright Reports | N/A | Wright Industry Averages: Health, Medicine and Pharmaceuticals (Global) | 144 | $169 | View Abstract |
| 7-Feb-10 | Wright Reports | N/A | Wright Industry Averages: Health, Medicine and Pharmaceuticals (North America) | 100 | $169 | View Abstract |
| 7-Feb-10 | Wright Reports | N/A | Wright Industry Averages: Health, Medicine and Pharmaceuticals (United States) | 98 | $169 | View Abstract |
| 7-Feb-10 | Pechala's Reports | Frantisek Pechala | STRYKER CORP (SYK=US) 12-months forecast | 1 | $15 | View Abstract |